Massachusetts Psychedelics Legalization Initiative Poised to Fail
Top 3 Health Care Stocks You'll Regret Missing In November
BTIG Maintains COMPASS Pathways(CMPS.US) With Buy Rating, Maintains Target Price $12
Morgan Stanley Maintains COMPASS Pathways(CMPS.US) With Buy Rating, Maintains Target Price $17
Massachusetts may become the next stop for legalization, is it a good investment opportunity for psychedelic drug concept stocks?
On Tuesday, Massachusetts voters will decide whether the state will legalize psilocybin, a hallucinogenic compound found in "magic mushrooms," worth noting for related concept stocks.
Legalizing Psychedelics: Is Massachusetts Next?